Two enzymes from the protein disulphide isomerase (PDI) family enable prostate cancer cells to grow, survive, and resist treatment. This discovery, however, could be taken as an advantage to improve ...
Morning Overview on MSN
Experimental prostate cancer drug shrinks tumors in early clinical trial
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one ...
Doctors have long looked to the hormone testosterone as a piece of the prostate cancer puzzle. The man on the other end was J. Bruce Hunsicker, an Akron-based lawyer with prostate cancer who had ...
Joseph J. Busch, Jr., M.D. , a board-certified radiologist and Founder of the Busch Center in Alpharetta, GA, will give a presentation titled "Robotic Assisted MRI-Guided Transurethral Ultrasound ...
New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...
SBRT Delays Systemic Therapy in Oligometastatic Cancers For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently delay the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results